Recruiting now—Ages 18 Years and up

BostonGene and Exigent Genomic INsight Study

Sponsor: BostonGene · NCT06272864 on ClinicalTrials.gov ↗

Conditions studied

Breast CancerNon-small Cell Lung CancerMelanomaSarcoma

Where it's running7 sites

Highlands Oncology Group
Rogers, Arkansas 72758
Recruiting now
- Adam Torres(contact)[email protected]
- Eric Schaefer, MD(principal investigator)
Stockton Hematology Oncology Medical Group
Stockton, California 95204
Recruiting now
- Lizbeth Ortiz(contact)[email protected]
- Dheeraj Kodali, MD(principal investigator)
Fort Wayne Medical Oncology and Hematology
Fort Wayne, Indiana 46804
Recruiting now
- Phil Huston(contact)[email protected]
- Sunil Babu, MD(principal investigator)
New Mexico Cancer Center
Albuquerque, New Mexico 87109
Recruiting now
- Valerie Tucker(contact)[email protected]
- Katherine Sanchez, MD(principal investigator)
Oklahoma Cancer Specialists and Research Institute
Tulsa, Oklahoma 74146
Recruiting now
- Ruth Dunn(contact)[email protected]
- Paul Zito, MD(principal investigator)
Oncology Consultants
Houston, Texas 77030
Recruiting now
- Laura Guerra(contact)[email protected]
- Julio Peguero, MD(principal investigator)
Northwest Medical Specialities
Puyallup, Washington 98373
Recruiting now
- Malee Chhan(contact)[email protected]
- Sibel Blau, MD(principal investigator)

See the official eligibility language

Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.

Inclusion Criteria:

* Patients must have a confirmed malignancy of:

Locally recurrent, unresectable, or metastatic breast cancer or; Unresectable stage III or metastatic non-small cell lung cancer or; Unresectable or metastatic melanoma or; Locally advanced or metastatic l sarcoma.

* Life expectancy \> 3 months as per the treating physician
* Willingness to provide informed consent
* Living in the United States at time of enrollment
* Agree to participate in genomic and molecular profiling

Exclusion Criteria:

* not meeting the inclusion criteria

Updated 2025-02-17 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.